Institutional shares held 24.3 Million
0 calls
0 puts
Total value of holdings $18.3M
$0 calls
$0 puts
Market Cap $28.2M
37,641,500 Shares Out.
Institutional ownership 64.66%
# of Institutions 40


Latest Institutional Activity in BOLT

Top Purchases

Q1 2024
Newtyn Management, LLC Shares Held: 1.7M ($1.28M)
Q1 2024
Vanguard Group Inc Shares Held: 1.04M ($778K)
Q1 2024
Renaissance Technologies LLC Shares Held: 518K ($388K)
Q1 2024
Acuitas Investments, LLC Shares Held: 518K ($388K)
Q1 2024
Prudential Financial Inc Shares Held: 35.2K ($26.4K)

Top Sells

Q1 2024
Tang Capital Management LLC Shares Held: 3.42M ($2.57M)
Q1 2024
Morgan Stanley Shares Held: 24.7K ($18.5K)
Q1 2024
Citadel Advisors LLC Shares Held: 2.42M ($1.81M)
Q1 2024
Two Sigma Securities, LLC Shares Held: 23.8K ($17.9K)
Q1 2024
Xtx Topco LTD Shares Held: 12.8K ($9.62K)

About BOLT

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.


Insider Transactions at BOLT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
10K Shares
From 1 Insiders
Open market or private purchase 10K shares
Sell / Disposition
289K Shares
From 2 Insiders
Open market or private sale 289K shares

Track Institutional and Insider Activities on BOLT

Follow Bolt Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BOLT shares.

Notify only if

Insider Trading

Get notified when an Bolt Biotherapeutics, Inc. insider buys or sells BOLT shares.

Notify only if

News

Receive news related to Bolt Biotherapeutics, Inc.

Track Activities on BOLT